Tirzepatide for Fat Loss
Weight & Glucose Manager.
Why Tirzepatide for fat loss?
A once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
Fat Loss context: Reducing body fat percentage through appetite regulation, lipolysis, or metabolic upregulation. Tirzepatide fits this goal because its category (Metabolic) and benefit profile align with the underlying mechanism.
Benefits relevant to fat loss
- Weight loss
- Appetite suppression
Reference dosing by bodyweight
Anchored to the most-cited research dose (5000 mcg @ 75 kg). Reference only.
| Bodyweight band | Reference dose range |
|---|---|
| <60 kg / <132 lb | 3117–4217 mcg |
| 60–75 kg / 132–165 lb | 3825–5175 mcg |
| 75–90 kg / 165–198 lb | 4675–6325 mcg |
| 90–105 kg / 198–231 lb | 5525–7475 mcg |
| >105 kg / >231 lb | 6375–8625 mcg |
Side effects to weigh against fat loss benefit
- Nausea
- Stomach pain
- Diarrhea
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.